Literature DB >> 22538014

Sphingomyelin synthase 2 over-expression induces expression of aortic inflammatory biomarkers and decreases circulating EPCs in ApoE KO mice.

Ya-Rui Zhao1, Ji-Bin Dong, Yue Li, Man-Ping Wu.   

Abstract

AIMS: This study sought to assess the effect of sphingomyelin synthase 2 (SMS2) over-expression on plaque component and endothelial dysfunction in atherosclerosis. MAIN
METHODS: We generated recombinant adenovirus vectors containing human SMS2 cDNA (AdV-SMS2) or control gene GFP cDNA (AdV-GFP). Both AdVs were injected (i.v.) into ApoE KO mice to establish SMS2 over-expressing and control mice models, respectively. The mice were fed a high fat diet for 30 days. We then examined their plasma lipid levels, expression levels of aortic inflammatory biomarkers critical for the plaque's stability, and numbers of peripheral endothelial progenitor cells (EPC). KEY
FINDINGS: Compared with the control mice, SMS2 over-expression had significantly (1) increased aortic matrix metalloproteinase-2 (MMP-2), monocyte chemoattractant protein-1 (MCP-1), tissue factor (TF) and cyclooxygenase-2 (COX-2) mRNA levels (1.9-fold, 2.2-fold, 2.6-fold and 3.2-fold, respectively, P<0.01) and protein levels (2.2-fold, 1.9-fold, 1.9-fold and 2.1-fold, respectively, P<0.01); (2) increased MMP-2, COX-2 in situ expression in aortic root (2.6-fold and 2.3-fold, respectively, P<0.01); (3) decreased aortic COX-1 mRNA levels (65%, P<0.01) and protein levels (64%, P<0.01); and (4) decreased CD34/KDR-positive cells (33%, P<0.01), circulating angiogenic cells (CACs) (50%, P<0.05), and colony forming units (CFUs) (40%, P<0.05) in circulation. SIGNIFICANCE: SMS2 over-expression was probably associated with increased expression of aortic inflammatory biomarkers, as well as decreased numbers of CD34/KDR-positive cells, CACs and CFUs in circulation. Therefore, SMS2 over-expression might correlate with endothelial dysfunction and aggravate atherosclerotic plaque instability in ApoE KO mice.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22538014     DOI: 10.1016/j.lfs.2012.04.003

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  12 in total

Review 1.  Sphingolipids and Lipoproteins in Health and Metabolic Disorders.

Authors:  Jahangir Iqbal; Meghan T Walsh; Samar M Hammad; M Mahmood Hussain
Journal:  Trends Endocrinol Metab       Date:  2017-04-24       Impact factor: 12.015

Review 2.  Ceramides and other sphingolipids as drivers of cardiovascular disease.

Authors:  Ran Hee Choi; Sean M Tatum; J David Symons; Scott A Summers; William L Holland
Journal:  Nat Rev Cardiol       Date:  2021-03-26       Impact factor: 49.421

Review 3.  Endothelial progenitor cells in ischemic stroke: an exploration from hypothesis to therapy.

Authors:  Ya-Feng Li; Li-Na Ren; Geng Guo; Lee Anne Cannella; Valeria Chernaya; Sonia Samuel; Su-Xuan Liu; Hong Wang; Xiao-Feng Yang
Journal:  J Hematol Oncol       Date:  2015-04-11       Impact factor: 17.388

Review 4.  Dietary and Endogenous Sphingolipid Metabolism in Chronic Inflammation.

Authors:  Gregory H Norris; Christopher N Blesso
Journal:  Nutrients       Date:  2017-10-28       Impact factor: 5.717

5.  Changes of plasmalogen phospholipid levels during differentiation of induced pluripotent stem cells 409B2 to endothelial phenotype cells.

Authors:  Yusuke Nakamura; Yasuo Shimizu; Yasuhiro Horibata; Rinna Tei; Ryosuke Koike; Meitetsu Masawa; Taiji Watanabe; Taichi Shiobara; Ryo Arai; Kazuyuki Chibana; Akihiro Takemasa; Hiroyuki Sugimoto; Yoshiki Ishii
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379

Review 6.  Potential therapeutic targets for atherosclerosis in sphingolipid metabolism.

Authors:  Zemou Yu; Qing Peng; Yining Huang
Journal:  Clin Sci (Lond)       Date:  2019-03-19       Impact factor: 6.124

7.  Population-based case-control study revealed metabolomic biomarkers of suboptimal health status in Chinese population-potential utility for innovative approach by predictive, preventive, and personalized medicine.

Authors:  Hao Wang; Qiuyue Tian; Jie Zhang; Hongqi Liu; Xiaoyu Zhang; Weijie Cao; Jinxia Zhang; Enoch Odame Anto; Xingang Li; Xueqing Wang; Di Liu; Yulu Zheng; Zheng Guo; Lijuan Wu; Manshu Song; Youxin Wang; Wei Wang
Journal:  EPMA J       Date:  2020-03-23       Impact factor: 6.543

8.  Epidermal growth factor gene is a newly identified candidate gene for gout.

Authors:  Lin Han; Chunwei Cao; Zhaotong Jia; Shiguo Liu; Zhen Liu; Ruosai Xin; Can Wang; Xinde Li; Wei Ren; Xuefeng Wang; Changgui Li
Journal:  Sci Rep       Date:  2016-08-10       Impact factor: 4.379

Review 9.  Sphingolipids in High Fat Diet and Obesity-Related Diseases.

Authors:  Songhwa Choi; Ashley J Snider
Journal:  Mediators Inflamm       Date:  2015-11-16       Impact factor: 4.711

10.  Decreased Count and Dysfunction of Circulating EPCs in Postmenopausal Hypercholesterolemic Females via Reducing NO Production.

Authors:  Ying Luo; Quan-Neng Yan; Wan-Zhou Wu; Fan-Yan Luo
Journal:  Stem Cells Int       Date:  2018-04-11       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.